Roche Polska Sp. z o.o.
+ business areaBioPharma R&D+Services
+ annual revenue
2020 - 2,000,000,000 PLN
2021 - 2,300,000,000 PLN
2022 - 2,700,000,000 PLN
+ workforce (estimated if not reported)
2024 - 848
+ depreciation & amortization
2020 - 10,500,000 PLN
2021 - 9,000,000 PLN
2022 - 8,800,000 PLN
Polish branch of the global Roche Group operating across three business areas: Pharma, Diagnostics, and Informatics. Focused on delivering innovative medicines, advanced diagnostic systems, and digital health solutions. Conducts clinical research, develops AI-driven healthcare platforms (e.g. NAVIFY), and supports precision medicine initiatives in Poland.